• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Hospital Readmissions Reduction Program associated with increased 30-day post-discharge mortality for heart failure and pneumonia                                                      

byQasim HussainiandDaniel Fisher
December 25, 2018
in Cardiology, Public Health, Pulmonology
Reading Time: 2 mins read
Treatment of subclinical hypothyroidism ineffective in older adults
Share on FacebookShare on TwitterShare on LinkedIn

1. In this retrospective cohort study, implementation of the Hospital Readmissions Reduction Program (HRRP) was unexpectedly associated with an increase in 30-day post-discharge mortality for heart failure and pneumonia but not for acute myocardial infarction.

2. There was a lack of association between the HRRP implementation and 45-day post-discharge mortality.

Evidence Rating Level: 2 (Good)           

Study Rundown: The Hospital Readmissions Reductions Program (HRRP) was established under the Affordable Care Act in 2010, implemented in 2012, and imposed financial penalties on hospitals that had higher-than-expected 30-day readmission rates for patients with heart failure (HF), acute myocardial infarction (AMI), and pneumonia. However, it was unclear if the program would lead to more careful discharge planning and better discharge outcomes. In this retrospective cohort review, patients with HF and pneumonia had increased 30-day post-discharge mortality after both announcement and implementation of the policy than before. Among patients with AMI, 30-day post-discharge mortality declined after the announcement and remained stable after implementation. No significant associations between HRRP and 45-day post-discharge mortality were found for any of the subpopulations.

Overall, the study shows surprising results whereby, in an attempt to lower readmission rates, HRRP may have resulted in increased mortality. However, it is unclear why the 30-day but not 45-day time point was associated with increased mortality, and the limitations of the study as a retrospective cohort may have contributed to this unexpected finding. Further research is needed to truly understand if the effects were a result of this policy.

Click to read the study, published today in JAMA

RELATED REPORTS

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

2 Minute Medicine Rewind July 20, 2026

Relevant Reading: Hospital Readmissions Reduction Program

In-Depth [retrospective cohort]: This study utilized Medicare Provider Analysis and Review files to identify hospital admissions and discharges at short-term acute care hospitals from April 1, 2005, through March 31, 2015. Medicare beneficiaries aged 65 years or older with a principle discharge diagnosis of heart failure (HF), acute myocardial infarction (AMI), or pneumonia were evaluated. The study identified 4 study periods of equal duration for the index hospitalization. These were non-overlapping periods and included the following: two periods before Hospital Readmissions Reduction Program (HRRP) announcement (period 1, April 2005-September 2007 and period 2, October 2007-March 2010), a period after HRRP announcement (period 3, April 2010-September 2012), and a period after HRRP implementation (period 4, October 2012-March 2015). Primary outcomes included 30-day post-discharge patient mortality for HF, AMI, and pneumonia. For patients with HF, post-discharge mortality increased before announcement (0.27% increase from period 1 to period 2), with announcement (0.49% increase from period 2 to period 3; P = 0.01), and after implementation of the policy (0.52% increase from period 3 to period 4, P = 0.001). Among patients with pneumonia, post-discharge mortality increased both with announcement (0.04% increase from period 1 to period 2) and implementation of the policy (0.44% post-HRRP implementation, P < 0.001). Finally, among patients with AMI, 30-day post-discharge mortality declined with announcement (0.18% pre-HRRP increase vs 0.08% post-HRRP announcement decrease, P = 0.01%), and remained stable after implementation. There were no significant associations for the 45-day time point (p > 0.05).

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: heart failureHospital Readmissions Reduction Programmyocardial infarctionpneumonia
Previous Post

Sorafenib increases progression-free survival in patients with desmoid tumors

Next Post

Genetic variants of increased waist-to-hip ratios associated with diabetes and coronary disease

RelatedReports

A man is sleeping on his side with a caution symbol and tape beside him, while lung images are in the background, suggesting a focus on sleep and respiratory health.
Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Weekly Rewinds

2 Minute Medicine Rewind July 20, 2026

July 20, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Polycythemia is not associated with increased mortality in heart failure

April 28, 2026
Prescription of antibiotics for acute respiratory infections increasing
Infectious Disease

Shorter antibiotic courses non-inferior for inpatient community-acquired pneumonia

April 13, 2026
Next Post
Many new pediatric asthma cases attributable to obesity

Genetic variants of increased waist-to-hip ratios associated with diabetes and coronary disease

#VisualAbstract: Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis

#VisualAbstract: Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis

Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified

2 Minute Medicine Rewind December 24, 2018

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy
  • A reduced length protocol for peripheral magnetic stimulation may be as effective compared to standard length protocol for upper trapezius myofascial pain syndrome
  • Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Limited-time Deep research trial
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.